Consequently, this modulation influences the severity of various ailments such as Alzheimer’s disease, myocardial disorders, and diabetes by impacting the expression of pro-inflammatory cytokines like IL-1β, IL-6, TNF-α, and type 1 interferons. This evidence concerns the gene IL1B and myocardial disorder.